The gut-skin connection

Skin and gut health are often treated as separate topics, but current research increasingly views them as part of a connected biological system. The gut microbiota influences skin function through immune, metabolic, and neuroendocrine pathways. When the gut microbiome becomes imbalanced (dysbiosis), it may increase intestinal permeability, shift microbial metabolites, and intensify systemic inflammatory signalling—all of which can eventually manifest in the skin. Recent reviews from 2025 describe this “gut–skin axis” as particularly relevant in conditions such as acne, atopic dermatitis, psoriasis, and rosacea, with factors like short-chain fatty acids, barrier integrity, and cytokine activity acting as key links between the gut and the skin.

This relationship is important because the skin is not just a surface barrier. It functions as an immune organ, a protective shield, a sensory interface, and a habitat for its own microbiome. When the gut ecosystem is stable, it tends to support a more balanced immune response; when it is disrupted, it can contribute to increased inflammatory activity and weakened barrier function in the skin. In atopic dermatitis, for example, recent literature highlights growing evidence that both intestinal and skin microbiome imbalances may work together to impair barrier integrity and disrupt immune regulation. Similar mechanisms are being explored in acne and psoriasis, although the exact pathways vary between conditions.

Clinical evidence is emerging but still inconsistent. A 2025 systematic review of microbiome-targeted interventions in dermatology, covering 60 randomized controlled trials, found that in atopic dermatitis, SCORAD scores improved compared with placebo in 30 out of 47 studies. However, results for psoriasis and acne were less consistent and more variable. At the same time, a 2024 randomized clinical trial in acne reported greater improvement in Global Acne Grading System scores with oral probiotic supplementation compared to placebo, suggesting that targeted microbiome modulation may have real—but condition-specific—effects.

Overall, the evidence does not support the idea of a universal “gut supplement” that reliably transforms skin health. Instead, the most consistent findings point toward broader lifestyle and dietary factors that support microbial balance, such as higher fiber intake, greater dietary diversity, and reduced inflammatory load. Public health guidance from organizations such as Johns Hopkins Medicine and the NHS similarly emphasizes fiber-rich, plant-forward diets as key to maintaining a healthy gut microbiome.

In this context, the gut–skin axis should be understood as a systems-level interaction rather than a quick fix: skin health reflects, in part, the state of the gut ecosystem, but improving it requires sustained support of overall metabolic, dietary, and inflammatory balance rather than a single intervention.